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INTRODUCTION 
1.1 TOPICAL DRUG DELIVERY SYSTEM 
Dermatologic products applied to skin are diverse in 
formulation and range in consistency from liquids to 
powders, but the most popular products are semisolid 
preparations. Semisolid preparations for dermatological 
use are generally delivered topically. Topical delivery can 
be defined as the application of a drug containing 
formulation to the skin to directly treat cutaneous 
disorders or general disease with the intent of possessing 
the pharmacological effect of the drug to the surface of 
the skin or within the skin. Topical preparations are 
frequently used for the localized effects at the site of their 
application by virtue of drug penetration into the 
underlying layers of the skin or mucous. Although some 
unintended drug absorption may occur, it is sub 
therapeutics quantities and generally of minor concern. 
The majority of topical products comprise semisolid 
formulations that include ointments, creams and gels. But 
the Drug penetration is Rate-Limiting Factor related to 
the Stratum Corneum. Where the carriers in which drug 
should be entrapped to enhance the topical delivery into 
the Dermis is required. The SC pore size is approximately 
less than 20 nm in the healthy volunteer So that the small 
particle sized carriers are required to enhance the drug 
permeation 1. 
a. Advantages of Topical Drug delivery System 
 Better patient compliance and avoidance of first pass 
metabolism. 
 Avoid fluctuations in drug levels, inter and 
intrapatient variations. 
 Avoid the Gastro intestinal incompatibility. 
 Provide utilization of drugs with short biological half 
life which have narrow therapeutic window. 
 Avoidance of the risk and inconvenience of 
intravenous therapy  
 Achievements of efficacy terminate the medications, 
when needed. 
 A relatively large area of application in comparison 
with buccal or nasal cavity 1 
b.  Disadvantages of Topical Drug Delivery Systems 
 Skin irritation or contact dermatitis may occur due to 
the drug and excipients. 
 Poor penetration of hydrophilic drugs through the 
skin. 
 Possibility of allergenic reactions. 
 Enzyme in epidermis may denature the drugs. 
 Drugs of larger particle size are not easily absorbed 
through the skin 1 
1.2 ANATOMY AND PHYSIOLOGY OF SKIN 
The skin acts as a boundary which separates the external 
environment from the internal organs. The epidermis acts 
as a barrier between the varied conditions of the external 
surroundings and the controlled internal environment of 
the living tissues and body fluids. The skin provides 
physical protection of internal organs and acts as a 
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sensory organ. It controls body temperature and water 
loss, and functions as a regulatory barrier which controls 
the movement of substances into and out of the body. The 
skin has gained increasing favors as a target site for drug 
delivery as it avoids problems associated with oral drug 
administration, namely pH and to some extent, enzyme 
driven drug degradation and hepatic first-pass 
metabolism. Cutaneous drug administration is not 
however without its problems. The drug is subjected to 
the skin’s own first-pass metabolic effect. In addition to 
this, percutaneous absorption is subject to significant 
variability owing to differences in age, race, sex, site of 
administration, species, presence or absence of disease 
and the skin’s reservoir capacity for a specific drug. 
There are numerous diseases which affect different 
regions of the skin. Any drug used will be required to 
reach the site of the disease in order to exert its 
pharmacological activity. Unless it is for a local effect on 
the surface only, the drug must either pass through the 
Stratum Corneum (SC) or go through hair follicles or 
sweat glands to reach its target site. Once in the skin, a 
lipid-soluble drug will tend to accumulate in lipophilic 
regions while more water-soluble drugs will tend to enter 
the blood capillaries and are removed from the skin 2.
 
Figure 1.1: Human skin parts 3 
1.2.1 Structure of Skin 
1.2.1.1 Epidermis 
The important function of the epidermis is the generation 
of the SC. The epidermis is avascular and is sustained by 
nutrients it receives by diffusion from the underlying 
dermal capillaries through the basement membrane. The 
epidermal layer forms as a result of the death of basal 
cells via a specialized differentiate process. The 
epidermis consists of two layers namely the non-viable 
epidermis (SC) and the viable epidermis 4.   
 The Non-Viable Epidermis (SC) 
This is the outermost layer of the epidermis. It is 
approximately 10-20 micro meter thick and consists of 
about 15-25 layers of flattened, hexagonal and dead 
cornified cells surrounded by intercellular lipid. The SC is 
a very dense layer of tissue (1.4 g/cm3 in the dry state). 
Approximately 15 % of the protein content of the SC 
consists of enzymes and other non-keratin proteins. The 
barrier function of the SC is enabled by the continuous 
desquamation of the non-viable epidermis with a total 
turnover of the SC occurring once every 2-3 weeks. 
Highly lipophilic compounds may be less absorbed 
systemically as they may be sequestered in the horny 
layer. The SC prevents loss of internal body components 
especially water. 
 The Viable Epidermis 
The cells of the SC are generated by the viable epidermis 
layer of cells. The Viable epidermis consists of several 
cell layers at varying stages of cell differentiation. These 
layers are the stratum granulosum, the stratum spinosum 
and the stratum basale or basal layer. The cells of viable 
epidermis themselves originate from the basal lamina or 
basement membrane which is located between the dermis 
and the viable epidermis. 
In order of increasing temperature, there are three phases, 
orthorhombic, hexagonal and fluid lamellar. The 
orthorhombic phase is densest.  The hydrocarbon chains 
of crystalline state are not equally distributed in the 
lattice, resulting in two different distances between lattice 
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planes (0.37 nm and 0.41 nm).  The hexagonal phase is 
equally distributed for its hydrocarbon chains, the lattice 
spacing is 0.41 nm. In fluid lamellar phase, the lipids are 
present in a liquid (molten) state. The interchain distance 
of liquid state is around 0.46 nm. The mosaic fluid model 
described by Forslind is the first model postulating the 
presence of a continuous liquid phase in the SC and of its 
coexistence with the gel-phase domains (crystalline 
phases) but there has been no experimental data allowing 
possible verification of this model. 5 
1.2.1.2 The Dermis 
The dermis is the connective tissue layer which supports 
the overlying epidermis. It consists mainly of fibrous 
protein collagen which is secreted by the dermal 
fibroblasts. The dermis also contains elastin fibers which 
form a mesh of fine threads, interspaced by collagen, 
around the hair follicles and sweat glands. In addition to 
the collagen and elastin tissue, various other substances 
occur in the dermis. These include mucopolysaccharides 
and soluble trophocollagen. The dermis contains 
superficial capillaries, sensory nerves, sebaceous glands, 
sweat glands and hair follicles as in fig. 1.1. 5 
1.2.1.3 The Subcutaneous Layer 
The subcutaneous tissue is a fatty layer which develops 
beneath the dermis. It is also called the hypodermis and it 
is the innermost layer of the skin. Its most important role 
is to hold the vessels and nerves that supply into the skin. 
It connects to the dermis through the aid of collagen and 
elastin fibers and firmly attaches the skin to the 
underlying muscle tissue. 5 
1.3 SOLID LIPID NANOPARTICLES 
Solid lipid nanoparticles are the nano-carriers which 
remain solid at room temperature and changes into liquid 
form while melting at increasing temperature. SLN are 
composed of 0.1% (w/w) to 30% (w/w) solid lipid 
dispersed in an aqueous medium and if necessary 
stabilized with preferably 0.5% (w/w) to 5% (w/w) 
surfactant. The incorporation of cosmetic and 
pharmaceutical actives is feasible. The mean particle size 
of SLN is in the submicron rage, ranging from about 40 
to 1000nm. In the second generation of the lipid 
nanoparticle technology, the particles are produced using 
blends of solid lipids and liquid lipids (oils). To obtain the 
blends for the particles matrix, solid lipids are mixed with 
liquid lipids (oils), preferably in a ratio of 70:30 upto a 
ratio of 99.9:0.1. The major advantage of SLN is the 
possibility of production on large industrial scale. 
However, depending on the drug some potential problems 
can occur, such as drug leakage during storage and 
insufficient total drug load. To overcome the limitations 
of SLN, nanostructured lipid carriers (NLC) have been 
developed. The later consists of a solid lipid matrix with a 
high content of liquid lipid. 7 
 
 
Figure 1.2: Formation of an almost perfect crystalline 
structure in SLN (left). Formation of a solid particle matrix 
of NLC (right)  
Table 1.1: Lipids and emulsifiers used for preparation 
of solid lipid nanoparticles 
6 
Lipids Emulsifiers/Coemulsifiers 
Triglycerides Soybean lecithin 
Tricaprin (Lipoid S 75, Lipoid S 100) 
Trilaurin Egg lecithin (Lipoid E 80) 
Trimyristin Phosphatidylcholine 
Tripalmitin (Epikuron 170, Epikuron 200) 
Tristearin Poloxamer 188 
Hydrogenated coco- 
glycerides (Softisan) Poloxamer 182 
Hard fat types Poloxamine 908 
Witepsol W 32 Tyloxapol 
Witepsol H 35 Polysorbate 20 
Witepsol H 42 Polysorbate 60 
Witepsol E 85 Polysorbate 80 
Glyceryl monostearate  
(Imwitor 900) Sodium cholate 
Glyceryl behenate  
(Compritol 888 ATO) Sodium glycocholate 
Glyceryl palmitostearate  
(Precirol ATO 5) Taurocholic acid sodium salt 
Cetyl palmitate Taurodeoxycholic acid sodium salt 
Stearic acid Butanol 
Palmitic acid Butyric acid 
Decanoic acid Dioctyl sodium sulfosuccinate 
Behenic acid Monooctylphosphoric acid sodium 
 
1.4 ADVANTAGES AND DISADVANTAGES OF 
THE SLN 
a. Advantages of SLN 
 Possibility of controlled drug release and drug 
targeting 
 Increased drug stability 
 High drug Payload  
 Incorporation of lipophilic and hydrophilic drugs 
feasible 
 No biotoxicity of the carrier 
 Avoidance of organic solvents 
 No problems with respect to large scale production 
and sterilization 
 b. Disadvantages of SLN 
 Lipid crystallization modifications 
 Drug Expulsion 
 Particles aggregation could be possible 8
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1.5 MECHANISM OF DRUG PENETRATION ACROSS THE SKIN 
 
Figure 1.3: Nanoparticle or microparticle drug delivery to the skin 9 where SC indicates the Stratum Corneum, E indicates 
the Epidermis, and D indicates the Dermis. 
1.5.1 This system is divided into three steps 
1. Penetration, the entry of a substance into a particular 
skin layer. 
2. Permeation, the penetration through one layer into 
another. 
3. Resorption, the uptake into the vascular system.5  
1.5.2 Mechanisms of penetration enhancement and 
epidermal targeting 
The nanoparticles and microparticles are formed in this 
project where the need to describe the drug entry through 
these carriers to the skin. Improved dermal absorption of 
the API loaded to lipid carriers may result from the 
increased contact surface of API and corneocytes, skin 
occlusion, rapid and steady release, and the surfactant 
effects. Small particles can make close contact to the SC 
surface i.e. superficial junctions of the corneocytes 
clusters and furrows between corneocyte islands may 
favor accumulation for many hours allowing to the 
sustained release. SLN and NLC should attach as they are 
for longer and remain at the application site because of a 
pronounced adhesive effect. However, it is necessary that 
the adhesiveness is directly proportional to the decrease 
in the particle size. The dissolved and finely dispersed 
drug into the carrier may facilitate the dermal absorption 
by close contact as well as occlusive effect. SLN are the 
solid lipids which remains solid at room temperature, so 
application of a SLN or NLC dispersion or lipid particle 
loaded cream or gel to the skin surface induces the 
structural changes of particle structure. Water evaporation 
results in a transition of the lipid matrix to a more highly 
ordered structure leading to drug expulsion. Improved 
hydration at least temporarily opens the compact structure 
of the horny layer, and the permeability of the barrier 
increases. The solid matrix of the particles is covered by a 
softer shell, possibly composed of amphiphilic glycerides 
with unesterified hydroxyl groups, surfactants and water 
which facilitate the API enrichment. The close contact 
made by active compound either attached to the particle 
surface or dissolved in fluid lipid covering the surface of 
NLC, to epidermal lipids due to spreading of the API. 
Penetration by SLN is more significant by Penetration 
enhancers, because in general potent enhancers are also 
potent irritants. Examples of penetration enhancers are 
Ethanol, Span 80, Tween 80 and even sodium cholate. 10 
Three pathways of penetration of the SC have been 
identified and these are transcellular, intercellular and 
appendageal as discussed in Fig. 1.4 
 
Figure 1.4: Sketch of the three penetration pathways: intracellular, intercellular and follicular. The upper right inset is a 
close-up of the stratum corneum showing the intracellular pathway and the tortuous intercellular pathway 5 
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1.5.3.1 The Intercellular Route 
5 
This route of drug absorption appears to predominate for 
most compounds. It has been suggested that the 
pharmacological agents applied diffuse through the SC 
in-between cells following a concentration gradient. That 
is to say that the drug substances move in the intercellular 
lipids which exist between keratinocytes in the SC. The 
rate at which the solute moves through the SC and the 
skin in this manner is indicated by the diffusion 
coefficient which considers factors that may hinder the 
diffusion of the solute such as the tortuosity of the 
diffusion pathway, the viscosity of the fluids the solute 
must diffuse through and protein binding of the solute as 
it moves through the skin. 
1.5.3.2 The Appendageal Route 
The two main appendages concerned with this type of 
penetration are the hair follicles and sweat glands. These 
openings effectively bypass the SC barrier to reach the 
underlying dermal structures. The role of appendages in 
transdermal drug penetration has been found to be 
controversial. Early studies using human skin suggested 
that a follicular or ‘shunt’ pathway could possibly be 
important immediately following topical drug application, 
however, because of its larger surface area, the 
intercellular pathway becomes dominant after application. 
As hair follicle density increases the follicular route of 
drug penetration may become more significant than it has 
been shown to be in human studies. In humans, the 
appendageal route is unlikely on account of the limited 
surface area available. 5 
1.5.3.3 The Intracellular Route 
Although the transcellular route makes maximal use of 
the available surface area for absorption, it is considered 
to be an unlikely route of administration because of the 
numerous repetitive partitioning steps of the solute 
between the several lipophilic and hydrophilic strata in 
the skin. In vivo experiments and morphology studies 
show that the transcellular route is implausible and that 
the intercellular path is more likely. 5 
1.6 THE MAIN FACTORS RELATED WITH 
SLN ADMINISTRATION TO TOPICAL ROUTE 
1.6.1 Method of preparation  
It influences the structures of the SLN. The drug enriched 
shell and drug enriched core are of two types of 
crystallization structures. As in Fig. 1.5, the former is 
obtained while repartitioning of the drug while cooling. 
And the drug enriched core will be found in case the drug 
precipitates first before the lipid recrystallizes. It is 
obtained when dissolving a drug in the lipid melt at or 
close to its saturation solubility. Cooling of the 
nanoemulsion will lead to a super saturation of drug in 
the melted lipid and subsequently to the drug 
crystallization prior to the lipid crystallization. 
 
Figure 1.5: Models of incorporated actives in lipid nanoparticles, homogeneous matrix (left), active-free lipid core 
with active-enriched shell (middle) and active-enriched core With active-free lipid shell (right) 
1.6.2 Degree of Crystallization  
The polymorphic form is also a parameter to determine 
the drug incorporation. The SLN are produced from solid 
lipids only and after preparation at least a part of the 
particles crystallizes in a higher energy modification 
(alpha or beta’). During storage, these modifications can 
transform to the low energy, more ordered beta 
modification. Due to its high degree of order, the number 
of imperfections in the crystal lattice is reduced leading to 
drug expulsion. 7 The main factors to transformations are 
temperature and water loss in the SLN nanodispersion. 
1.6.3 Adhesiveness 
 It is a general property of the very fine particles that 
means nanoparticles of different kinds. Such a lipid film 
formation will be able to restore a damaged protective 
lipid film on the skin. Such a film can have occlusive 
effect. 
1.6.4 Occlusive effect 
The occlusive effect is caused by following the 
evaporation of water from the lipid nanodispersion 
applied to the skin surface; lipid particles form an 
adhesive layer occluding the skin surface. Then hydration 
of the stratum corneum may increase which by reducing 
corneocyte packing and widening of the inter-corneocytes 
gaps can facilitate drug partitioning into deeper skin 
strata. Occlusive factor generally appear strongly related 
to the particle size. Nanoparticles have 15-fold more 
occlusive than microparticles.10 The occlusive effect of 
the SLN membrane was evaluated by using Cream base, 
SLN-containing cream base and gel formulations which 
were incubated at 24 h. where TEWL (Transepidermal 
water loss) was determined for each for the moisture 
content in the SLN was present. As in fig. 1.6, it has 
shown that, 33 % moisture was present in the skin area as 
compared to the 23% of formulation having SLN-Free 
base. 8
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Figure 1.6: Microscopic pictures of untreated porcine skin (upper), skin treated 
With cream base (middle) and with SLN-containing cream base (lower) 
CONCLUSION 
The solid lipid nanoparticles are thus promising drug 
delivery carriers for drug delivery through the topical 
route. These are small nano-sized particles having 
lipophilic property. The water-insoluble drug can be 
penetrated through skin by solubilized in these carriers. 
The film forming property and close contact of the solid 
lipid nanoparticles to penetrate the drug through the skin 
helps in improving controlled release. The chemical 
degradation can be easily avoided due to its lipophilic 
property. The main factors affect drug delivery of solid 
lipid nanoparticles through skin are Method of 
preparation, degree of crystallization, adhesive effect and 
occlusive factor. These factors represent optimal delivery 
of drug in controlled manner through skin.  
 
REFERENCE 
1. Walters K A, Roberts M S. The structure and foundation of 
skin. In: Dermatological and transdermal formulations. Eds 
K.A. Walters, New York: Marcel Dekker; 2002.1-40. 
2. Johnson ME, Blankschein D, Linger R. Evaluation of solute 
permeation through the stratum corneum lateral bilayer 
diffusion as the primary transport mechanism. J Pharm Sci 
1997; 86 (10): 1162-1172. 
3. http://www.sciencekids.co.nz/pictures/humanbody/skindiagr
am.html 
4. Elias J, The Microscopic Structure of the Epidermis and Its 
Derivatives. In: Percutaneous Absorption, 2nd ed., Eds 
Bronaugh R L, Maibach H I, New York: Marcel Dekker, Inc; 
1989. 3-12. 
5. Bolzinger M A, Briancon S, Pelletier J, Chevalier Y. 
Penetration of drugs through skin, a complex rate controlling 
membrane. Current opinion in colloid and interface science 
2012; 17: 156-165. 
6. Mader K, Mehnert W. Solid lipid nanoparticles Production, 
Characterization and applications. Advanced drug delivery 
reviews 2011; 47: 165-196. 
7. Muller R H, Pardeike J, Hommoss A. Lipid nanoparticles 
(SLN, NLC) in cosmetic and Pharmaceutical dermal 
products. International journal of pharmaceutics 2009; 366: 
170-184. 
8. Gohla S, Muller R H, Mader K. Solid lipid nanoparticles 
(SLN) for Controlled drug delivery- a review of the state of 
the art- Review article. European journal of pharmaceutics 
and biopharmaceutics 2000; 50: 161-177. 
9. Roberts MS, Prow TW, Grice JE, Lin LL, Faye R, Butler M 
et al. Nanoparticles and microparticles for skin drug delivery. 
Advanced drug delivery reviews 2011; 63: 470-491. 
10. Schafer-Korting M, Mehnert W, Korting HC. Lipid 
nanoparticles for improved topical application of drugs for 
skin diseases. Advanced drug delivery reviews 2007; 59: 
427-443. 
 
 
 
 
